Concord Medical Services Holdings Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Concord Medical Services Holdings Limited generated cash of -$276,471,000, which is less than the previous year. Cash used in financing activities reached the amount of $257,653,000 last year. Net change in cash is therefore -$68,924,000.
Cash Flow
| 2014 | 490.38M | 287.05M | -579.14M |
|---|---|---|---|
| 2015 | -175.13M | -391.08M | 590.39M |
| 2016 | -78.07M | -74.84M | -131.37M |
| 2017 | 26.73M | -313.01M | 189.89M |
| 2018 | -38.59M | -1.00B | 1.20B |
| 2019 | -195.34M | -1.07B | 513.26M |
| 2020 | -229.76M | -533.88M | 1.13B |
| 2021 | -359.31M | -565.98M | 642.44M |
| 2022 | -216.69M | -118.79M | 383.08M |
| 2023 | -276.47M | -47.68M | 257.65M |
CCM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 159.34M | 158.91M | 446.39M | 74.30M | 826.73M | 662.17M | 758.39M | 485.44M | 478.68M | 283.03M |
Operating activities | ||||||||||
Net income | -297.65M | -489.66M | -522.67M | -404.02M | -307.04M | -259.29M | -284.32M | -265.08M | -78.30M | 120.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 128.45M | 132.81M | 104.08M | 80.29M | 65.81M | 54.62M | 94.70M | 129.00M | 158.34M | 201.67M |
Stock-based compensation expense | 0 | -5.91M | 14.68M | 20.62M | 20.59M | 0 | 11.64M | 8.4M | 8.08M | 7.34M |
| Deferred income tax benefit | 0 | -5.91M | 14.68M | 20.62M | 20.59M | 0 | 11.64M | 8.4M | 8.08M | 7.34M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 36.45M | 644K | -64.45M | -6.16M | 3.57M | 48.38M | 43.40M | 9.92M | 43.27M | 4.50M |
Inventories | 44.48M | -46.75M | -4.35M | -14.44M | -1.82M | 1.80M | -554K | -1.92M | 315K | 237K |
Accounts payable | 0 | 0 | 262.84M | 11.11M | 0 | 530K | 0 | 6.96M | 0 | 31.28M |
Cash generated by operating activities | -276.47M | -216.69M | -359.31M | -229.76M | -195.34M | -38.59M | 26.73M | -78.07M | -175.13M | 490.38M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 209.12M | -108.49M | 0 | -252.25M | 0 | -181.5M | 0 | 0 |
Investments In Property Plant And Equipment | -115.70M | -383.77M | -780.29M | -512.90M | -700.92M | -766.17M | -289.10M | -121.97M | -181.97M | -109.85M |
Acquisitions Net | 0 | 0 | -66.02M | 62.39M | -525.67M | -330.88M | 0 | 39.19M | -321.14M | -6.53M |
Cash generated by investing activities | -47.68M | -118.79M | -565.98M | -533.88M | -1.07B | -1.00B | -313.01M | -74.84M | -391.08M | 287.05M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 139.97M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -285.82M | 0 | -453.56M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.40M | -19.72M | 0 |
Repayments of term debt | 62.81M | 363.21M | -230.76M | -1.27B | 680.57M | -1.61B | 463.04M | -978.30M | 391.83M | -392.44M |
Cash used in financing activities | 257.65M | 383.08M | 642.44M | 1.13B | 513.26M | 1.20B | 189.89M | -131.37M | 590.39M | -579.14M |
Net Change In Cash | -68.92M | 432K | -287.48M | 372.08M | -752.42M | 164.55M | -96.22M | -295.53M | 6.75M | 195.64M |
Cash at end of period | 90.41M | 159.34M | 158.91M | 446.39M | 74.30M | 826.73M | 662.17M | 189.90M | 485.44M | 478.68M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |